Corcept Therapeutics: Despite FDA Blind Side, Relacorilant Remains A Viable Drug

Company Overview - Corcept Therapeutics is a commercial-stage biotech company focused on treatments for cortisol modulation, particularly related to Cushing's Syndrome [1] Product Information - Since 2012, the company has marketed Korlym as a treatment for Cushing's Syndrome [1]